Oladoctor – online healthcare marketplace in Spain

Medicamentos con risedronic acid en Spain

R
Dosage form:  TABLET, 75 mg
Active substance:  risedronic acid
Prescription required
Dosage form:  TABLET, 35 mg
Active substance:  risedronic acid
Prescription required
Dosage form:  TABLET, 35 mg
Active substance:  risedronic acid
Prescription required
Dosage form:  TABLET, 35 mg
Active substance:  risedronic acid
Prescription required
Dosage form:  TABLET, 35 mg
Active substance:  risedronic acid
Manufacturer:  Laboratorio Stada S.L.
Prescription required
Dosage form:  TABLET, 35 mg
Active substance:  risedronic acid
Prescription required
Dosage form:  TABLET, 75 mg
Active substance:  risedronic acid
Manufacturer:  Laboratorio Stada S.L.
Prescription required
Dosage form:  TABLET, 75 mg
Active substance:  risedronic acid
Prescription required
Dosage form:  TABLET, 75 mg
Active substance:  risedronic acid
Prescription required
Dosage form:  TABLET, 75 mg
Active substance:  risedronic acid
Prescription required
Dosage form:  TABLET, 75 mg
Active substance:  risedronic acid
Manufacturer:  Neuraxpharm Spain S.L.
Prescription required
Dosage form:  TABLET, 35 mg
Active substance:  risedronic acid
Prescription required
Dosage form:  Film‑coated tablet, 40.17 mg
Active substance:  risedronic acid
Prescription required
Dosage form:  TABLET, 35 mg
Active substance:  risedronic acid
Prescription required
Dosage form:  TABLET, 35 mg
Active substance:  risedronic acid
Prescription required
Dosage form:  TABLET, 35 mg
Active substance:  risedronic acid
Manufacturer:  Kern Pharma S.L.
Prescription required
Dosage form:  TABLET, 35 mg
Active substance:  risedronic acid
Manufacturer:  Neuraxpharm Spain S.L.
Prescription required
Dosage form:  TABLET, 35 mg
Active substance:  risedronic acid
Manufacturer:  Viatris Limited
Prescription required
Dosage form:  TABLET, 75 mg
Active substance:  risedronic acid
Prescription required
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media